This site is intended for healthcare professionals
News

Eli LIlly acquires Disarm Therapeutics and gains access to SARMI inhibitors to treat axonal degeneration

Read time: 1 mins
Last updated:16th Oct 2020
Published:17th Oct 2020
Type: industry
Register free for full access to medthority.com